Följ
Trent M. Woodruff
Trent M. Woodruff
Verifierad e-postadress på uq.edu.au - Startsida
Titel
Citeras av
Citeras av
År
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
7382019
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
TM Woodruff, J Thundyil, SC Tang, CG Sobey, SM Taylor, TV Arumugam
Molecular neurodegeneration 6, 1-19, 2011
7372011
Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment
KD Beck, HX Nguyen, MD Galvan, DL Salazar, TM Woodruff, ...
Brain 133 (2), 433-447, 2010
6542010
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
R Gordon, EA Albornoz, DC Christie, MR Langley, V Kumar, S Mantovani, ...
Science translational medicine 10 (465), eaah4066, 2018
5612018
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ...
Science 352 (6292), aad1210, 2016
4702016
The role of the complement system in ischemia-reperfusion injury
TV Arumugam, IA Shiels, TM Woodruff, DN Granger, SM Taylor
Shock 21 (5), 401-409, 2004
4562004
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
4422021
Toll-like receptors in ischemia-reperfusion injury
TV Arumugam, E Okun, SC Tang, J Thundyil, SM Taylor, TM Woodruff
Shock 32 (1), 4-16, 2009
4082009
Inhibiting the C5–C5a receptor axis
TM Woodruff, KS Nandakumar, F Tedesco
Molecular immunology 48 (14), 1631-1642, 2011
3452011
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
3072017
Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth
LG Coulthard, TM Woodruff
The Journal of Immunology 194 (8), 3542-3548, 2015
2812015
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer’s disease
MI Fonseca, RR Ager, SH Chu, O Yazan, SD Sanderson, FM LaFerla, ...
The Journal of Immunology 183 (2), 1375-1383, 2009
2732009
Neutrophils—a key component of ischemia-reperfusion injury
ZV Schofield, TM Woodruff, R Halai, MCL Wu, MA Cooper
Shock 40 (6), 463-470, 2013
2482013
C5L2: a controversial receptor of complement anaphylatoxin, C5a
R Li, LG Coulthard, MCL Wu, SM Taylor, TM Woodruff
The FASEB Journal 27 (3), 855-864, 2013
2322013
Eph/Ephrin signaling in injury and inflammation
MG Coulthard, M Morgan, TM Woodruff, TV Arumugam, SM Taylor, ...
The American journal of pathology 181 (5), 1493-1503, 2012
2262012
Complement component 5a (c5a)
HD Manthey, TM Woodruff, SM Taylor, PN Monk
The international journal of biochemistry & cell biology 41 (11), 2114-2117, 2009
2242009
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease
TM Woodruff, TV Arumugam, IA Shiels, RC Reid, DP Fairlie, SM Taylor
The Journal of Immunology 171 (10), 5514-5520, 2003
1942003
The role of the complement system and the activation fragment C5a in the central nervous system
TM Woodruff, RR Ager, AJ Tenner, PG Noakes, SM Taylor
Neuromolecular medicine 12, 179-192, 2010
1862010
Complement mediators in ischemia–reperfusion injury
TV Arumugam, T Magnus, TM Woodruff, LM Proctor, IA Shiels, SM Taylor
Clinica Chimica Acta 374 (1-2), 33-45, 2006
1852006
Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
TV Arumugam, TM Woodruff, JD Lathia, PK Selvaraj, MP Mattson, ...
Neuroscience 158 (3), 1074-1089, 2009
1822009
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20